David Vorchheimer

2.2k total citations
28 papers, 1.6k citations indexed

About

David Vorchheimer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, David Vorchheimer has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Internal Medicine. Recurrent topics in David Vorchheimer's work include Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Acute Myocardial Infarction Research (9 papers) and Atrial Fibrillation Management and Outcomes (6 papers). David Vorchheimer is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (13 papers), Acute Myocardial Infarction Research (9 papers) and Atrial Fibrillation Management and Outcomes (6 papers). David Vorchheimer collaborates with scholars based in United States, Canada and United Kingdom. David Vorchheimer's co-authors include Valentı́n Fuster, Robert A. Harrington, Nina Rieckmann, Karina W. Davidson, Ian M. Kronish, Richard Becker, Richard C. Becker, Christopher M. O’Connor, Gordon Guyatt and T W Meade and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

David Vorchheimer

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Vorchheimer United States 16 1.1k 391 361 175 129 28 1.6k
Jean R. Cusson Canada 18 1.1k 0.9× 590 1.5× 834 2.3× 229 1.3× 132 1.0× 42 1.9k
Jeffrey Lefkovits Australia 23 2.6k 2.3× 1.1k 2.8× 289 0.8× 335 1.9× 207 1.6× 138 3.5k
Michele Robertson United Kingdom 23 1.1k 1.0× 373 1.0× 83 0.2× 119 0.7× 110 0.9× 41 2.0k
Cian P. McCarthy United States 15 856 0.8× 373 1.0× 92 0.3× 50 0.3× 165 1.3× 39 1.3k
Sam L. Teichman United States 24 1.5k 1.3× 395 1.0× 153 0.4× 34 0.2× 169 1.3× 52 2.4k
Satish Sharma United States 17 1.1k 1.0× 361 0.9× 109 0.3× 132 0.8× 99 0.8× 46 1.8k
Martin Gottwik Germany 24 1.5k 1.4× 707 1.8× 120 0.3× 45 0.3× 82 0.6× 90 2.3k
PharmD United States 9 736 0.6× 158 0.4× 509 1.4× 91 0.5× 51 0.4× 150 1.5k
William A. Parker United Kingdom 18 310 0.3× 323 0.8× 150 0.4× 71 0.4× 148 1.1× 83 1.2k

Countries citing papers authored by David Vorchheimer

Since Specialization
Citations

This map shows the geographic impact of David Vorchheimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vorchheimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vorchheimer more than expected).

Fields of papers citing papers by David Vorchheimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Vorchheimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vorchheimer. The network helps show where David Vorchheimer may publish in the future.

Co-authorship network of co-authors of David Vorchheimer

This figure shows the co-authorship network connecting the top 25 collaborators of David Vorchheimer. A scholar is included among the top collaborators of David Vorchheimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Vorchheimer. David Vorchheimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Massera, Daniele, Dan Wang, David Vorchheimer, Abdissa Negassa, & Mario J. García. (2016). Increased risk of stroke and mortality following new-onset atrial fibrillation during hospitalization. EP Europace. 19(6). euw110–euw110. 12 indexed citations
3.
Vorchheimer, David, et al.. (2013). DABIGATRAN VERSUS STANDARD ANTITHROMBOTIC THERAPY FOR NEW ONSET NONVALVULAR ATRIAL FIBRILLATION: IMPACT ON HOSPITAL LENGTH OF STAY. Journal of the American College of Cardiology. 61(10). E377–E377. 1 indexed citations
4.
Zafar, M. Urooj, Carlos G. Santos‐Gallego, David Vorchheimer, et al.. (2012). Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation. Journal of Thrombosis and Haemostasis. 11(1). 100–106. 44 indexed citations
5.
Davidson, Karina W., Matthew M. Burg, Ian M. Kronish, et al.. (2010). Association of Anhedonia With Recurrent Major Adverse Cardiac Events and Mortality 1 Year After Acute Coronary Syndrome. Archives of General Psychiatry. 67(5). 480–480. 112 indexed citations
6.
Zafar, M. Urooj, Borja Ibáñez, Brian G. Choi, et al.. (2009). A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel in a randomised phase I study. Thrombosis and Haemostasis. 103(1). 205–212. 25 indexed citations
7.
Becker, Richard C., T W Meade, Peter B. Berger, et al.. (2008). The Primary and Secondary Prevention of Coronary Artery Disease. CHEST Journal. 133(6). 776S–814S. 176 indexed citations
8.
Zafar, M. Urooj, David Vorchheimer, Juan Gaztañaga, et al.. (2007). Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber. Thrombosis and Haemostasis. 98(10). 883–888. 102 indexed citations
9.
Rieckmann, Nina, Ian M. Kronish, Donald Haas, et al.. (2006). Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. American Heart Journal. 152(5). 922–927. 89 indexed citations
10.
Vilahur, Gemma, Brian G. Choi, M. Urooj Zafar, et al.. (2006). Normalization of platelet reactivity in clopidogrel‐treated subjects. Journal of Thrombosis and Haemostasis. 5(1). 82–90. 134 indexed citations
11.
Kronish, Ian M., Nina Rieckmann, Ethan A. Halm, et al.. (2006). Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. Journal of General Internal Medicine. 21(11). 1178–1183. 186 indexed citations
12.
Vorchheimer, David & Richard Becker. (2006). Platelets in Atherothrombosis. Mayo Clinic Proceedings. 81(1). 59–68. 96 indexed citations
13.
Harrington, Robert A., Richard C. Becker, Michael Ezekowitz, et al.. (2004). Antithrombotic Therapy for Coronary Artery Disease. CHEST Journal. 126(3). 513S–548S. 152 indexed citations
14.
Duvall, W. Lane & David Vorchheimer. (2004). Multi-Bed Vascular Disease and Atherothrombosis: Scope of the Problem. Journal of Thrombosis and Thrombolysis. 17(1). 51–61. 43 indexed citations
15.
Rauch, Ursula, Julio Osende, J H Chesebro, et al.. (2000). Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 153(1). 181–189. 123 indexed citations
16.
Vorchheimer, David. (1999). Current state of thrombolytic therapy. Current Cardiology Reports. 1(3). 212–220. 3 indexed citations
17.
Vorchheimer, David. (1999). Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease. JAMA. 281(15). 1407–1407. 86 indexed citations
18.
Rauch, Ursula, Juan J. Badimon, David Vorchheimer, et al.. (1998). Lipid lowering therapy reduces blood thrombogenicity in hypercholesterolemic patients: effect of simvastatin. Journal of the American College of Cardiology. 31. 194–194. 4 indexed citations
19.
Vorchheimer, David & Valentı́n Fuster. (1996). Coumadin aspirin reinfarction study: Rationale and design of the CARS study. Journal of Thrombosis and Thrombolysis. 2(3). 171–176. 2 indexed citations
20.
Vorchheimer, David, Lawrence Baruch, Marrick Kukin, et al.. (1996). Does the presence or absence of chest pain at initiation of thrombolysis in acute myocardial infarction affect outcome?. Journal of the American College of Cardiology. 27(2). 389–389. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean R. Cusson Breakdown of academic impact, for papers by Jeffrey Lefkovits Breakdown of academic impact, for papers by Michele Robertson Breakdown of academic impact, for papers by Cian P. McCarthy Breakdown of academic impact, for papers by Sam L. Teichman Breakdown of academic impact, for papers by Satish Sharma Breakdown of academic impact, for papers by Martin Gottwik Breakdown of academic impact, for papers by PharmD Breakdown of academic impact, for papers by William A. Parker
Rankless by CCL
2026